Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Meet Our Editorial Board Member free to download

Volume:16   Issue: 12
Pp: 1271-1271
Martina Sanderson-Smith
DOI: 10.2174/138945011612151014124554
Published on: 13 October, 2015



Editorial (Thematic Issue: From Multiple Hits to Multiple Therapeutic Targets of Non-alcoholic Fatty Liver Disease) free to download

Volume:16   Issue: 12
Pp: 1272-1273
Lixin Zhu, Robert D. Baker and Susan S. Baker
DOI: 10.2174/1389450116999150928154553
Published on: 13 October, 2015

Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism

Volume:16   Issue: 12
Pp: 1274-1280
Trudy M. Forte and Robert O. Ryan
DOI: 10.2174/1389450116666150531161138
Published on: 13 October, 2015


The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease

Volume:16   Issue: 12
Pp: 1281-1292
Guoxun Chen
DOI: 10.2174/1389450116666150325231015
Published on: 13 October, 2015


Identification of Lipid Species Linked to the Progression of Non-alcoholic Fatty Liver Disease

Volume:16   Issue: 12
Pp: 1293-1300
Yuki Kawano, Shin Nishiumi, Masaya Saito, Yoshihiko Yano, Takeshi Azuma and Masaru Yoshida
DOI: 10.2174/1389450116666150408103318
Published on: 13 October, 2015


Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease

Volume:16   Issue: 12
Pp: 1301-1314
Wensheng Liu, Susan S Baker, Robert D Baker and Lixin Zhu
DOI: 10.2174/1389450116666150427155342
Published on: 13 October, 2015


IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression

Volume:16   Issue: 12
Pp: 1315-1323
Daniel A Giles, Maria E Moreno-Fernandez and Senad Divanovic
DOI: 10.2174/1389450116666150531153627
Published on: 13 October, 2015


Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease

Volume:16   Issue: 12
Pp: 1324-1331
Marialena Mouzaki and Robert Bandsma
DOI: 10.2174/1389450116666150416120351
Published on: 13 October, 2015


Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?

Volume:16   Issue: 12
Pp: 1332-1346
Michele T. Pritchard and Jennifer M. McCracken
DOI: 10.2174/1389450116666150825111439
Published on: 13 October, 2015


Natural Products on Nonalcoholic Fatty Liver Disease

Volume:16   Issue: 12
Pp: 1347-1355
Jiao-Ya Xu, Li Zhang, Zhong-Ping Li and Guang Ji
DOI: 10.2174/1389450116666150531155711
Published on: 13 October, 2015


ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy

Volume:16   Issue: 12
Pp: 1356-1371
Haigang Cui, Anna J. Zhang, Mingwei Chen and Johnson J. Liu
DOI: 10.2174/1389450116666150330113506
Published on: 13 October, 2015


Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism

Volume:16   Issue: 12
Pp: 1372-1380
Xiu Zhou, Jun Xu, Yuguang Shi and Ji-Ming Ye
DOI: 10.2174/1389450116666150223120829
Published on: 13 October, 2015


A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential

Volume:16   Issue: 12
Pp: 1381-1403
Suresh Kumar, Alo Nag and Chandi C. Mandal
DOI: 10.2174/1389450116666150325231419
Published on: 13 October, 2015